Cochrane · systematic review · CD007323

Doxycycline for osteoarthritis of the knee or hip

da Costa, BR, Nüesch, E, Reichenbach, S, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library

Musculoskeletal2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 50%Moderate 3 · 50%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Comparison

Population: participants with osteoarthritis of the knee or hip
6 questions
OutcomeEffectEvidenceStatus / GRADE
Pain 10‐cm VAS scale (median
no estimate extracted2 studies · 524 participantsModerate
Downgraded: risk of bias, imprecision
Function WOMAC function (range 0 to 10) (median
no estimate extracted2 studies · 517 participantsModerate
Downgraded: risk of bias, imprecision
Minimum joint space width (
no estimate extracted1 study · 361 participantsModerate
Downgraded: risk of bias, imprecision
Number of participants experiencing any adverse event (
RR 1.36 [1.08, 1.72]1 study · 232 participantsLow
Downgraded: risk of bias, imprecision
Number of participants withdrawn due to adverse events (median
RR 2.28 [1.06, 4.9]2 studies · 663 participantsLow
Downgraded: risk of bias, imprecision
Number of participants experiencing any serious adverse event (median
RR 1.07 [0.68, 1.68]2 studies · 663 participantsLow
Downgraded: risk of bias, imprecision